Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Anne, Flint"'
Autor:
Niklas Giesa, Patrick Heeren, Sophie Klopfenstein, Anne Flint, Louis Agha-Mir-Salim, Akira Poncette, Felix Balzer, Sebastian Boie
Routinely collected electronic health records (EHR) in clinical information systems (CIS) are often heterogeneous, have inconsistent data formats and lack of documentation. We use the well-known open-source database schema of MIMIC-IV to address this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d444ee4ebc2a73a7099303bbaca8be2f
https://doi.org/10.3233/shti220522
https://doi.org/10.3233/shti220522
Autor:
Niklas, Giesa, Patrick, Heeren, Sophie, Klopfenstein, Anne, Flint, Louis, Agha-Mir-Salim, Akira, Poncette, Felix, Balzer, Sebastian, Boie
Publikováno v:
Studies in health technology and informatics. 294
Routinely collected electronic health records (EHR) in clinical information systems (CIS) are often heterogeneous, have inconsistent data formats and lack of documentation. We use the well-known open-source database schema of MIMIC-IV to address this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb1ca0b75ad403953bc5b70e93d11f62
https://pubmed.ncbi.nlm.nih.gov/35612143
https://pubmed.ncbi.nlm.nih.gov/35612143
Autor:
Anne Flint, Lotte Holm, Anne Raben, Søren T. Kristensen, Bente K. Møller, Nikolaj T. Gregersen, Arne Astrup
Publikováno v:
Food & Nutrition Research, Vol 55, Iss 0, Pp 1-10 (2011)
Appetite measures are often recorded by visual analogue scales (VAS), and are assumed to reflect central nervous system (CNS) perceptions and sensations. However, little is known about how physiological, psychological, social, and cultural factors in
Externí odkaz:
https://doaj.org/article/96058fc1be834577891be8dda7be5f23
Autor:
Arne Astrup, Jens Juul Holst, A. Christina Møller, Tatjana H. Vasilaris, Anne Flint, Bente K. Møller, Anne Raben
Publikováno v:
Food & Nutrition Research, Vol 55, Iss 0, Pp 1-13 (2011)
The importance of exchanging sucrose for artificial sweeteners on risk factors for developing diabetes and cardiovascular diseases is not yet clear. Objective: To investigate the effects of a diet high in sucrose versus a diet high in artificial swee
Externí odkaz:
https://doaj.org/article/a68ead2535dd46f9a1994f84d5305d6a
Autor:
Lars Johansson, Grit Andersen, Rohit Loomba, Mads Sundby Palle, Anni Morsing, Leona Plum-Mörschel, Paul D. Hockings, Anne Flint, Thomas J. Vogl
Publikováno v:
Alimentary pharmacology & therapeutics, vol 54, iss 9
BackgroundGlucagon-like peptide-1 receptor agonists may be a treatment option in patients with non-alcoholic fatty liver disease (NAFLD).AimsTo investigate the effects of semaglutide on liver stiffness and liver fat in subjects with NAFLD using non-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e5c7e57c718aa14129e2339ea0af88d
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/64497
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/64497
Autor:
Steen H. Ingwersen, Kristin C. Carlsson Petri, Thomas W. Anderson, Rune Viig Overgaard, Anne Flint, Philip Harder Delff
Publikováno v:
Diabetes Therapy
Introduction The aim of the present analysis was to characterise the absorption, distribution and elimination of semaglutide by means of population pharmacokinetic (PK) models using data from nine clinical pharmacology trials conducted in both health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df5fca6b90089cda197f99a241fd016
http://europepmc.org/articles/PMC6437231
http://europepmc.org/articles/PMC6437231
Autor:
Leona Plum-Mörschel, Anni Morsing, Paul D. Hockings, Mads Sundby Palle, Olivia Svolgaard, Anne Flint, Grit Andersen
Publikováno v:
Advances in Therapy
Introduction Non-alcoholic fatty liver disease (NAFLD), one of the most common liver diseases, is associated with liver-related complications and metabolic comorbidities. The phenotype is wide, ranging from simple steatosis to non-alcoholic steatohep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdab8c79c68500efa2c15fd2d6a277b6
https://pubmed.ncbi.nlm.nih.gov/33006125
https://pubmed.ncbi.nlm.nih.gov/33006125
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To evaluate dose levels for semaglutide, a glucagon-like peptide-1 analogue approved for the treatment of type 2 diabetes, by examining the effects of demographic factors on efficacy and safety in an exposure-response analysis. Methods We analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24174363a1445f8fd80a831b61d422b0
https://doi.org/10.1111/dom.13358
https://doi.org/10.1111/dom.13358
Publikováno v:
Diabetes Therapy
Introduction Semaglutide, a new treatment option approved for the treatment of patients with type 2 diabetes mellitus, is a glucagon-like peptide-1 receptor agonist to be injected subcutaneously once weekly. This analysis used a population pharmacoki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62ce1082a17d9bd5c6b9907d81d2ad31
https://doi.org/10.1007/s13300-018-0458-5
https://doi.org/10.1007/s13300-018-0458-5
Autor:
Valentin Demmel, Jonas Pettersson, Anne Sandberg-Schaal, Georg Golor, Anne Flint, Jacob Bonde Jacobsen
Publikováno v:
Diabetes Therapy
Introduction Semaglutide is a glucagon-like peptide-1 (GLP-1) analog approved for the once-weekly treatment of type 2 diabetes. The objective of this 16-week, double-blind, single-center thorough QT study was to confirm that semaglutide treatment doe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d8434c498e922ceff1a949de4289502
http://europepmc.org/articles/PMC6064589
http://europepmc.org/articles/PMC6064589